9 months ago
SLP
AnalystsBrett FishbinBrett Fishbin's Stock Forecasts
AnalystsBrett Fishbin
Analyst Ranking
Bottom 8%
#4671 out of 5067 analysts
Average Return
-3.58%
Win Rate
45%14 out of 31
Risk vs Reward
Poor
Good
Brett Fishbin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Icu Medical IncICUI | +70.01% | $95.00 | $161.51 | 2024-02-06 - 2025-02-05 | Strong Buy |
Integer Holdings CorpITGR | +41.87% | $99.39 | $141.00 | 2024-02-16 - 2025-02-14 | Strong Buy |
Integer Holdings CorpITGR | +35.10% | $105.37 | $142.35 | 2024-02-06 - 2025-02-05 | Strong Buy |
Icu Medical IncICUI | +33.13% | $112.48 | $149.75 | 2024-02-28 - 2025-02-27 | Strong Buy |
Resmed IncRMD | +27.19% | $190.72 | $242.58 | 2024-02-06 - 2025-02-05 | Strong Buy |
Brett Fishbin Analyst Color
Get additional color on Brett Fishbin's coverage of popular stocks
9 months ago
ITGR
a year ago
ICUI
a year ago
ITGR
a year ago
ICUI
a year ago
ALC
a year ago
STE
Brett Fishbin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Resmed IncRMD | 7 | Strong Buy | $298.00 | +10.37% | Maintains | 3 months ago |
Steris PLCSTE | 3 | Strong Buy | $288.00 | +19.85% | Maintains | 3 months ago |
Inspire Medical Systems IncINSP | 4 | Strong Buy | $197.00 | +154.72% | Maintains | 3 months ago |
Texas Instruments IncTXN | 1 | Strong Buy | $215.00 | +22.52% | Maintains | 6 months ago |
Alcon IncALC | 5 | Strong Buy | $112.00 | +48.54% | Maintains | 7 months ago |
Simulations Plus IncSLP | 1 | Strong Buy | $37.00 | +130.96% | Maintains | 9 months ago |
Integer Holdings CorpITGR | 5 | Strong Buy | $154.00 | +49.34% | Maintains | 9 months ago |
Icu Medical IncICUI | 5 | Strong Buy | $209.00 | +79.41% | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.